Search results
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 hours agoCorcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept...
Alzheimer's patients show stable cognition with INmune Bio's XPro By Investing.com
Investing.com· 2 days agoINmune Bio Inc. (NASDAQ:INMB), a clinical-stage immunology company, has reported that two...
Trump's brain exposed as a 'series of hazy corridors filled with dead ends': analysis
The Raw Story· 3 hours agoTime Magazine this week published a lengthy interview with former President Donald Trump this week...
Orangutan, Heal Thyself
New York Times· 5 hours agoFor the first time, scientists observed a primate in the wild treating a wound with a plant that has medicinal properties. Scientists observed a wild...
What is ‘sexsomnia’? Here’s what happens with this ‘dangerous’ sex sleep disorder
New York Post· 3 days agoHowever, it’s very difficult to study as because most people have no recollection of their actions...
Orangutan's use of medicinal plant to treat wound intrigues scientists
Reuters· 4 hours agoIn June 2022, a male Sumatran orangutan named Rakus sustained a facial wound below the right eye,...
Want Boosted Brain Power? Walk While You Work
Bicycling via Yahoo News· 2 days agoNew research points to the benefits of getting more movement at work. This holds true even for those who ride regularly, but tend to sit most of the day.
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 2 days agoBiogen's Leqembi gained full approval for Alzheimer's treatment based on its ability to remove...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 9 hours ago, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tuesday. Huntington's disease is an inherited condition that causes the ...
Q1 2024 Corcept Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoHypertension and hyperglycemia are among the most common and destructive. Patients in the open-label phase of GRACE exhibited clinically meaningful and statistically significant improvements ...
